Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Examine funds that maximize after-tax gains for retirement. This overview focuses on tax efficiency and long-term retirement growth.
27,364 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Guardian (GRDN) is shaping up as a data-driven growth story in 2026. This deep dive breaks down the Q1 2026 earnings ...
Nu Holdings has shown impressive growth, but the true challenge lies in weathering a credit cycle. This guide explain...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...
SpaceX’s public debut reframes who wins in venture capital, with Founders Fund and Andreessen Horowitz among the marq...
Semiconductor ETFs are leading the charge on U.S. exchanges, pushing chip-focused funds onto the most-traded lists. T...
A new defense-focused ETF began trading in July 2026, joining VistaShares’ space and robotics funds as investors chas...
A Nashville case highlights a troubling form of elder financial exploitation. Learn how scams work, the signs to watc...
This week’s CPI data could tilt policy expectations: a hotter print may bolster a hawkish stance from the new Fed lea...
A social-media frenzy around trillionaire wealth centers on Elon Musk, sparking a debate about how market values, pri...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...